Protein inhibitors to complement and VEGF pathways and methods of use thereof

The invention provides bispecific fusion proteins that inhibit activation of complement pathway and vascular endothelial growth factor (VEGF) pathway and methods for using these fusion proteins.

Saved in:
Bibliographic Details
Main Authors Chen, Huang-Tsu, Her, Jeng-Horng
Format Patent
LanguageEnglish
Published 06.12.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention provides bispecific fusion proteins that inhibit activation of complement pathway and vascular endothelial growth factor (VEGF) pathway and methods for using these fusion proteins.
Bibliography:Application Number: US201815965382